News & Updates
Filter by Specialty:
Is there a link between vertigo and psychiatric disorders?
A systematic review and meta-analysis from Singapore suggest a potential association between benign paroxysmal positional vertigo (BPPV) and anxiety.
Is there a link between vertigo and psychiatric disorders?
30 Nov 2023Psychological burden high in women with threatened miscarriage
A substantial proportion of women with threatened miscarriage show distress as well as depressive and anxiety symptoms, researchers from the University of Hong Kong have reported.
Psychological burden high in women with threatened miscarriage
30 Nov 2023Subcutaneous risperidone delays impending relapse in schizophrenia
Subcutaneous injection of risperidone QM or Q2M (TV-46000) has been shown to significantly delay impending relapse in patients with schizophrenia in the phase III RISE study.
Subcutaneous risperidone delays impending relapse in schizophrenia
10 Nov 2023Sexual dysfunction affects >50 percent of patients with schizophrenia
Sexual dysfunction is highly prevalent in schizophrenia, affecting >50 percent of patients. Treatment of comorbid depression may be an effective strategy to improve sexual health, according to a meta-analysis.
Sexual dysfunction affects >50 percent of patients with schizophrenia
09 Nov 2023Brexpiprazole improves agitation in Alzheimer’s dementia
A double-blind, placebo-controlled, randomized clinical trial reports significant improvement in agitation with brexpiprazole vs placebo among patients with Alzheimer’s dementia.
Brexpiprazole improves agitation in Alzheimer’s dementia
09 Nov 2023IBS symptoms tied to depression, anxiety in NAFLD patients
Patients with nonalcoholic fatty liver disease (NAFLD) tend to have higher rates of irritable bowel syndrome (IBS) symptoms, depression, and anxiety, suggests a study.
IBS symptoms tied to depression, anxiety in NAFLD patients
04 Nov 2023Esketamine outperforms quetiapine in head-to-head depression trial
In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.